申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:US20040133008A1
公开(公告)日:2004-07-08
A compound of the formula (I)
1
wherein
R
1
is hydrogen, lower alkyl, lower alkenyl, halo(lower)alkyl, cyclo(lower)alkyl, lower alkoxy, lower alkylthio, acyl, optionally substituted aryl or NR
3
R
4
;
R
2
is hydrogen; or aryl or heteroaryl, each of which may be substituted;
X is direct bond or bivalent residue derived from piperazine;
Y is -(A
1
)
n
-(A
2
)
m
-, wherein n and m are independently 0 or 1);
2
is bivalent residue derived from arene or heteroarene; and
3
is bivalent residue derived from arene or heteroarene, or a salt thereof. The compound of the present invention and a salt thereof inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.
化合物的式子为(I)1,其中R1为氢、低级烷基、低级烯基、卤素(低)烷基、环(低)烷基、低级烷氧基、低级烷硫基、酰基、可选取代的芳基或NR3R4;R2为氢;或芳基或杂环芳基,每个可以被取代;X为直接键或由哌嗪衍生的二价残基;Y为-(A1)n-(A2)m-,其中n和m独立地为0或1);2为由芳烃或杂芳烃衍生的二价残基;3为由芳烃或杂芳烃衍生的二价残基,或其盐。本发明的化合物及其盐抑制载脂蛋白B(Apo B)的分泌,并可用作预防和治疗由高循环Apo B水平引起的疾病或状况的药物。